Capreomycin sulfate: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Capreomycin sulfate}} {{CMG}} ==Overview== ==Category== ==US Brand Names== ==FDA Package Insert== '''Description''' '''| ..." |
|||
Line 8: | Line 8: | ||
==US Brand Names== | ==US Brand Names== | ||
CAPASTAT SULFATE<sup>®</sup> | |||
==FDA Package Insert== | ==FDA Package Insert== |
Revision as of 21:51, 24 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Category
US Brand Names
CAPASTAT SULFATE®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages